Skip to search formSkip to main contentSkip to account menu

Milligram per Square Meter per Minute

Known as: Milligram/Square Meter/Minute, mg/m2/min 
A dose calculation unit expressed in milligram(s) per square meter per period of time equal to sixty seconds.
National Institutes of Health

Related topics

Related topics

1 relation
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Carmustine infusion reactions are more common with rapid administration
PurposeCarmustine is a nitrosurea alkylating agent predominantly used at Peter MacCallum Cancer Centre as part of the autologous… 
2012
2012
Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients
PurposeThere is no standard regimen for gemcitabine (Gem)-refractory pancreatic cancer (PC) patients. In a previous phase II… 
2006
2006
Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree: series of 106 consecutive patients.
14099 Background: Our group recently published a phase II trial of GEM infused at fixed dose-rate of 10 mg/m2/min over 100 min in… 
2004
2004
A phase I clinical trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced squamous cell cancer of the head…
Background: Preclinical data suggested that sustained inhibition of the anabolic enzyme, ribonucleotide reductase (RR), by… 
Highly Cited
2004
Highly Cited
2004
A Phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors
Purpose: Pharmacological studies of gemcitabine (2′,2′-difluorodeoxycytidine) have shown that increased levels of the active… 
2002
2002
Phase I Study of Gemcitabine (Difluorodeoxycytidine) in Children with Relapsed or Refractory Leukemia (CCG-0955): A Report from the Children's Cancer Group
To determine the maximum tolerated dose (MTD) and assess the toxicity profile and pharmacokinetics of weekly gemcitabine… 
Review
2002
Review
2002
A comprehensive update on the use of chemotherapy for metastatic pancreatic adenocarcinoma.
2000
2000
A combination of a fixed dose rate infusion of gemcitabine associated to a bolus 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer…
BACKGROUND Laboratory evidences suggest the possibility that an infusion rate of 10 mg/m2/min may be more effective than the… 
1993
1993
Correction of Hyperinsulinemia by Glyburide Treatment in Nondiabetic Patients with Thalassemia Major
ABSTRACT: Hyperinsulinemia and insulin resistance precede the development of diabetes in patients with thalassemia major on… 
1985
1985
Quantitation of Insulin-stimulated Glucose Disposal in Patients with Non-insulin-dependent Diabetes Mellitus
Glucose disposal rates (Rd) during an insulin clamp study reflect both basal and insulin-stimulated Rd. To quantify the amount of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)